Pfizer Inc (PFE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 11,188,000 | 21,355,000 | 7,246,000 | 6,986,000 | 9,168,000 |
| Depreciation Amortization | 6,150,000 | 6,269,000 | 5,757,000 | 5,157,000 | 5,537,000 |
| Income taxes - deferred | -2,204,000 | -2,410,000 | -700,000 | -20,000 | 317,000 |
| Accounts receivable | -458,000 | 259,000 | -134,000 | 21,000 | 148,000 |
| Other Working Capital | -334,000 | 1,334,000 | 98,000 | 741,000 | 1,623,000 |
| Other Operating Activity | 1,485,000 | -10,005,000 | 3,925,000 | 1,803,000 | 291,000 |
| Operating Cash Flow | $15,827,000 | $16,802,000 | $16,192,000 | $14,688,000 | $17,084,000 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 1,987,000 | -2,236,000 | 9,239,000 | 17,251,000 | 350,000 |
| PPE Investments | -1,984,000 | -1,956,000 | -1,823,000 | -1,397,000 | -1,199,000 |
| Net Acquisitions | N/A | -1,000,000 | -18,368,000 | -16,466,000 | -195,000 |
| Purchase Of Investment | -1,797,000 | -3,537,000 | -8,011,000 | -9,542,000 | -10,718,000 |
| Sale Of Investment | 6,244,000 | 3,579,000 | 11,268,000 | 6,929,000 | 6,145,000 |
| Purchase Sale Intangibles | -152,000 | -261,000 | -176,000 | -99,000 | -384,000 |
| Other Investing Activity | 75,000 | 410,000 | -96,000 | 245,000 | -37,000 |
| Investing Cash Flow | $4,525,000 | $-4,740,000 | $-7,791,000 | $-2,980,000 | $-5,654,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 2,094,000 | 9,886,000 | 4,412,000 | 8,274,000 | -1,828,000 |
| Debt Issued | 4,974,000 | 5,274,000 | 10,976,000 | N/A | 4,491,000 |
| Debt Repayment | -3,566,000 | -6,154,000 | -7,689,000 | -2,990,000 | -2,110,000 |
| Common Stock Issued | 1,259,000 | 862,000 | 1,019,000 | 1,263,000 | 1,002,000 |
| Common Stock Repurchased | -12,198,000 | -5,000,000 | -5,000,000 | -6,160,000 | -5,000,000 |
| Dividend Paid | -7,978,000 | -7,659,000 | -7,317,000 | -6,940,000 | -6,609,000 |
| Other Financing Activity | -5,026,000 | -10,559,000 | -5,629,000 | -3,856,000 | -133,000 |
| Financing Cash Flow | $-20,441,000 | $-13,350,000 | $-9,228,000 | $-10,409,000 | $-10,187,000 |
| Exchange Rate Effect | -116,000 | 53,000 | -215,000 | -1,000,000 | -83,000 |
| Beginning Cash Position | 1,431,000 | 2,666,000 | 3,707,000 | 3,343,000 | 2,183,000 |
| End Cash Position | 1,225,000 | 1,431,000 | 2,666,000 | 3,641,000 | 3,343,000 |
| Net Cash Flow | $-205,000 | $-1,235,000 | $-1,041,000 | $298,000 | $1,160,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 15,827,000 | 16,802,000 | 16,192,000 | 14,688,000 | 17,084,000 |
| Capital Expenditure | -1,984,000 | -1,956,000 | -1,823,000 | -1,397,000 | -1,199,000 |
| Free Cash Flow | 13,843,000 | 14,846,000 | 14,369,000 | 13,291,000 | 15,885,000 |